Advances in the Management of HPV-Related Oropharyngeal Cancer
Patients with human papillomavirus- (HPV-) related oropharyngeal squamous cell carcinoma (OPSCC) have a better prognosis than HPV-negative OPSCC when treated with standard high-dose cisplatin-based chemoradiotherapy. Consistent with this assertion and due to younger age at diagnosis, novel approache...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2019/9173729 |
id |
doaj-938cda86ce1f41a893bd82ed757c9f0a |
---|---|
record_format |
Article |
spelling |
doaj-938cda86ce1f41a893bd82ed757c9f0a2020-11-24T21:51:05ZengHindawi LimitedJournal of Oncology1687-84501687-84692019-01-01201910.1155/2019/91737299173729Advances in the Management of HPV-Related Oropharyngeal CancerF. De Felice0V. Tombolini1V. Valentini2M. de Vincentiis3S. Mezi4O. Brugnoletti5A. Polimeni6Department of Radiotherapy, Policlinico Umberto I, “Sapienza” University of Rome, Rome, ItalyDepartment of Radiotherapy, Policlinico Umberto I, “Sapienza” University of Rome, Rome, ItalyDepartment of Oral and Maxillofacial Sciences, Policlinico Umberto I, “Sapienza” University of Rome, Rome, ItalyDepartment of Oral and Maxillofacial Sciences, Policlinico Umberto I, “Sapienza” University of Rome, Rome, ItalyDepartment of Medical Oncology, Policlinico Umberto I “Sapienza” University of Rome, Rome, ItalyDepartment of Oral and Maxillofacial Sciences, Policlinico Umberto I, “Sapienza” University of Rome, Rome, ItalyDepartment of Oral and Maxillofacial Sciences, Policlinico Umberto I, “Sapienza” University of Rome, Rome, ItalyPatients with human papillomavirus- (HPV-) related oropharyngeal squamous cell carcinoma (OPSCC) have a better prognosis than HPV-negative OPSCC when treated with standard high-dose cisplatin-based chemoradiotherapy. Consistent with this assertion and due to younger age at diagnosis, novel approaches to minimize treatment sequelae while preserving survival outcomes become of paramount importance. Here, we critically reviewed the evidence-based literature supporting the deintensification strategies in HPV-related OPSCC management, including radiotherapy dose and/or volume reduction, replacement of cisplatin radiosensitising chemotherapy, and the use of transoral surgery. Undoubtedly, further researches are needed before changing the standard of care in this setting of patients.http://dx.doi.org/10.1155/2019/9173729 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
F. De Felice V. Tombolini V. Valentini M. de Vincentiis S. Mezi O. Brugnoletti A. Polimeni |
spellingShingle |
F. De Felice V. Tombolini V. Valentini M. de Vincentiis S. Mezi O. Brugnoletti A. Polimeni Advances in the Management of HPV-Related Oropharyngeal Cancer Journal of Oncology |
author_facet |
F. De Felice V. Tombolini V. Valentini M. de Vincentiis S. Mezi O. Brugnoletti A. Polimeni |
author_sort |
F. De Felice |
title |
Advances in the Management of HPV-Related Oropharyngeal Cancer |
title_short |
Advances in the Management of HPV-Related Oropharyngeal Cancer |
title_full |
Advances in the Management of HPV-Related Oropharyngeal Cancer |
title_fullStr |
Advances in the Management of HPV-Related Oropharyngeal Cancer |
title_full_unstemmed |
Advances in the Management of HPV-Related Oropharyngeal Cancer |
title_sort |
advances in the management of hpv-related oropharyngeal cancer |
publisher |
Hindawi Limited |
series |
Journal of Oncology |
issn |
1687-8450 1687-8469 |
publishDate |
2019-01-01 |
description |
Patients with human papillomavirus- (HPV-) related oropharyngeal squamous cell carcinoma (OPSCC) have a better prognosis than HPV-negative OPSCC when treated with standard high-dose cisplatin-based chemoradiotherapy. Consistent with this assertion and due to younger age at diagnosis, novel approaches to minimize treatment sequelae while preserving survival outcomes become of paramount importance. Here, we critically reviewed the evidence-based literature supporting the deintensification strategies in HPV-related OPSCC management, including radiotherapy dose and/or volume reduction, replacement of cisplatin radiosensitising chemotherapy, and the use of transoral surgery. Undoubtedly, further researches are needed before changing the standard of care in this setting of patients. |
url |
http://dx.doi.org/10.1155/2019/9173729 |
work_keys_str_mv |
AT fdefelice advancesinthemanagementofhpvrelatedoropharyngealcancer AT vtombolini advancesinthemanagementofhpvrelatedoropharyngealcancer AT vvalentini advancesinthemanagementofhpvrelatedoropharyngealcancer AT mdevincentiis advancesinthemanagementofhpvrelatedoropharyngealcancer AT smezi advancesinthemanagementofhpvrelatedoropharyngealcancer AT obrugnoletti advancesinthemanagementofhpvrelatedoropharyngealcancer AT apolimeni advancesinthemanagementofhpvrelatedoropharyngealcancer |
_version_ |
1725880622826651648 |